CA2199273A1 - Epimeres de (22rs)-n-(1,1,1-trifluoro-2-phenylprop-y-yl)-3-oxo-4-aza-5.alpha.-androst-1-ene-17.beta.-carboxamide - Google Patents
Epimeres de (22rs)-n-(1,1,1-trifluoro-2-phenylprop-y-yl)-3-oxo-4-aza-5.alpha.-androst-1-ene-17.beta.-carboxamideInfo
- Publication number
- CA2199273A1 CA2199273A1 CA002199273A CA2199273A CA2199273A1 CA 2199273 A1 CA2199273 A1 CA 2199273A1 CA 002199273 A CA002199273 A CA 002199273A CA 2199273 A CA2199273 A CA 2199273A CA 2199273 A1 CA2199273 A1 CA 2199273A1
- Authority
- CA
- Canada
- Prior art keywords
- epimers
- formula
- phenylprop
- trifluoro
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne les épimères (22R)-N-(1,1,1-trifluoro-2-phénylprop-2-yl)-3-oxo-4-aza-5.alpha.-androst-1-ène-17.beta.-carboxamide et (22S)-N-(1,1,1-trifluoro-2-phénylprop-2-yl)-3-oxo-4-aza-5.alpha.-androst-1-ène-17.beta.-carboxamide, servant d'inhibiteurs de la testostérone 5.alpha.-réductase. L'invention concerne également un procédé pour leur préparation et les compositions pharmaceutiques les contenant.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI95A001587 | 1995-07-21 | ||
IT95MI001587A IT1275594B1 (it) | 1995-07-21 | 1995-07-21 | Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2199273A1 true CA2199273A1 (fr) | 1997-02-06 |
Family
ID=11372032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002199273A Abandoned CA2199273A1 (fr) | 1995-07-21 | 1996-06-28 | Epimeres de (22rs)-n-(1,1,1-trifluoro-2-phenylprop-y-yl)-3-oxo-4-aza-5.alpha.-androst-1-ene-17.beta.-carboxamide |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0782582A1 (fr) |
JP (1) | JPH10506411A (fr) |
KR (1) | KR970706298A (fr) |
CN (1) | CN1159195A (fr) |
AR (1) | AR003967A1 (fr) |
AU (1) | AU6418396A (fr) |
BR (1) | BR9606527A (fr) |
CA (1) | CA2199273A1 (fr) |
EA (1) | EA199700045A1 (fr) |
HU (1) | HUP9702465A3 (fr) |
IL (1) | IL120343A0 (fr) |
IT (1) | IT1275594B1 (fr) |
MX (1) | MX9701948A (fr) |
NO (1) | NO971196D0 (fr) |
PL (1) | PL319351A1 (fr) |
WO (1) | WO1997004002A1 (fr) |
ZA (1) | ZA965678B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000013509A1 (fr) * | 1998-09-09 | 2000-03-16 | Merck & Co., Inc. | Procede de determination et de reduction du risque de survenue de problemes urologiques lies a l'adenome prostatique |
JP2002535274A (ja) * | 1999-01-25 | 2002-10-22 | スミスクライン・ビーチャム・コーポレイション | 抗アンドロゲン剤および疾病の治療方法 |
CN100355772C (zh) * | 2005-12-28 | 2007-12-19 | 天津大学 | 具有5α-还原酶抑制活性的甾体化合物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9216284D0 (en) * | 1992-07-31 | 1992-09-16 | Erba Carlo Spa | Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives |
-
1995
- 1995-07-21 IT IT95MI001587A patent/IT1275594B1/it active IP Right Grant
-
1996
- 1996-06-28 CN CN96190785A patent/CN1159195A/zh active Pending
- 1996-06-28 WO PCT/EP1996/002830 patent/WO1997004002A1/fr not_active Application Discontinuation
- 1996-06-28 EP EP96923968A patent/EP0782582A1/fr not_active Withdrawn
- 1996-06-28 MX MX9701948A patent/MX9701948A/es unknown
- 1996-06-28 IL IL12034396A patent/IL120343A0/xx unknown
- 1996-06-28 HU HU9702465A patent/HUP9702465A3/hu unknown
- 1996-06-28 BR BR9606527A patent/BR9606527A/pt not_active Application Discontinuation
- 1996-06-28 PL PL96319351A patent/PL319351A1/xx unknown
- 1996-06-28 AU AU64183/96A patent/AU6418396A/en not_active Abandoned
- 1996-06-28 JP JP9506217A patent/JPH10506411A/ja active Pending
- 1996-06-28 KR KR1019970701797A patent/KR970706298A/ko not_active Application Discontinuation
- 1996-06-28 CA CA002199273A patent/CA2199273A1/fr not_active Abandoned
- 1996-07-04 ZA ZA965678A patent/ZA965678B/xx unknown
- 1996-07-19 AR ARP960103652A patent/AR003967A1/es unknown
-
1997
- 1997-03-14 NO NO971196A patent/NO971196D0/no unknown
- 1997-04-18 EA EA199700045A patent/EA199700045A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
AU6418396A (en) | 1997-02-18 |
BR9606527A (pt) | 1997-12-23 |
AR003967A1 (es) | 1998-09-30 |
KR970706298A (ko) | 1997-11-03 |
PL319351A1 (en) | 1997-08-04 |
WO1997004002A1 (fr) | 1997-02-06 |
CN1159195A (zh) | 1997-09-10 |
ZA965678B (en) | 1997-01-24 |
NO971196L (no) | 1997-03-14 |
ITMI951587A0 (it) | 1995-07-21 |
HUP9702465A3 (en) | 1998-11-30 |
EP0782582A1 (fr) | 1997-07-09 |
EA199700045A1 (ru) | 1997-12-30 |
ITMI951587A1 (it) | 1997-01-21 |
NO971196D0 (no) | 1997-03-14 |
IL120343A0 (en) | 1997-06-10 |
MX9701948A (es) | 1997-06-28 |
IT1275594B1 (it) | 1997-08-06 |
JPH10506411A (ja) | 1998-06-23 |
HUP9702465A2 (hu) | 1998-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69113155T2 (de) | 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung. | |
EP0591057B1 (fr) | Arylalkyl(thio)amides ayant une affinité sélective pour les récepteurs de la mélatonine et leur procédé de préparation | |
CA2406847C (fr) | Oxydation stereoselective de systemes a cycles fusionnes pour la preparation d'aminosterols | |
EP0799239B1 (fr) | Derives diastereomeriquement purs du 3-oxo et du 3-thioxo-4-aza-androstane et emploi de ceux-ci comme androgenes | |
US5237061A (en) | Methods of synthesizing benign prostatic hypertropic agents and their intermediates | |
SK128494A3 (en) | Method of production of indanylamine compounds | |
JPH06511497A (ja) | フッ素化17β−置換,4−アザ−5α−アンドロスタン−3−オン誘導体 | |
NZ244640A (en) | 17beta-substituted aza-androstane derivatives; pharmaceutical compositions and preparatory processes | |
US4797411A (en) | Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors | |
CA2199273A1 (fr) | Epimeres de (22rs)-n-(1,1,1-trifluoro-2-phenylprop-y-yl)-3-oxo-4-aza-5.alpha.-androst-1-ene-17.beta.-carboxamide | |
HU198441B (en) | Process for production of derivatives of 4-amin-phenil substituated by cycloalkil group and their medically acceptable salts and medical compositions containing such compounds | |
FR2601011A1 (fr) | Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant | |
CA2253912C (fr) | Derives de taxane, leur preparation et formulations les contenant | |
DE69606623T2 (de) | Phenyl-substituierte 4-azasteroid-fluorderivate | |
Srivastava et al. | N-benzoyl-(2R, 3S)-3-phenylisoserine methyl ester; a facile and convenient synthesis and resolution by entrainment | |
MXPA97001948A (en) | Epimeros de (22rs-n- (1,1,1-trifluoro-2-fenilprop-2-il) -3-oxo-4-aza-5alfa-androst-1-en-17beta-carboxam | |
Heinrich et al. | Effective syntheses of quinoline-7, 8-diol, 5-amino-l-DOPA, and 3-(7, 8-dihydroxyquinolin-5-yl)-l-alanine | |
EP0276122B1 (fr) | Dérivés de halogéno 4-aminophényles substitués par des cycloalkyles et procédé pour leur préparation | |
US5583228A (en) | 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof | |
AU696320B2 (en) | 4-aza-19-norandrostane derivatives | |
IE60754B1 (en) | Steroidic aromatase inhibitors | |
JP2003509504A (ja) | リトナビルの合成方法 | |
BE1000112A5 (fr) | Procede de preparation d'encainide. | |
CN102838653B (zh) | 一种3-羰基-4-氮杂-5α-雄甾化合物的制备方法 | |
CN116217478A (zh) | 一种6-氨基-3-二氟甲基喹啉的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |